|
Ephrin-A2
|
D12.776.543.550.418.310 |
|
|
Religion and Medicine
|
D012068 |
[The interrelationship of medicine and religion.
] |
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels
|
D051676 |
[A family of inwardly-rectifying potassium channels that are activated by PERTUSSIS TOXIN sensitive G-PROTEIN-COUPLED RECEPTORS. GIRK potassium channels are primarily activated by the complex of GTP-BINDING PROTEIN BETA SUBUNITS and GTP-BINDING PROTEIN GAMMA SUBUNITS.
] |
|
Histiocytoma, Malignant Fibrous
|
D051677 |
[The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.
] |
|
Religion and Psychology
|
D012069 |
[The interrelationship of psychology and religion.
] |
|
Sickle Cell Trait
|
C16.320.365.155.668 |
|
|
Mice, Inbred mdx
|
B01.050.050.199.520.520.420.500 |
|
|
Mice, Inbred C57BL
|
B01.050.050.199.520.520.420 |
|
|
Hearing Loss, Central
|
C10.597.751.418.341.887.432 |
|
|
Sino-Nasal Outcome Test
|
N05.715.360.575.575.399.875.500 |
|
|
Patient Reported Outcome Measures
|
N05.715.360.575.575.399.875 |
|
|
Andrographis
|
B01.650.940.800.575.912.250.583.040.044 |
|
|
Chronic Kidney Disease-Mineral and Bone Disorder
|
D012080 |
[Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
] |
|
Renal Veins
|
D012082 |
[Short thick veins which return blood from the kidneys to the vena cava.
] |
|
Renin
|
D012083 |
[A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.
] |
|
Renin-Angiotensin System
|
D012084 |
[A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.
] |
|
Lung Abscess
|
C08.381.450 |
|
|
Aegle
|
B01.650.940.800.575.912.250.875.077 |
|
|
Safflower Oil
|
D10.627.700.840 |
|
|
Pyelonephritis
|
C13.351.968.419.570.821.717 |
|
